Corvus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $15.20 |
Previous Close | $15.11 |
Day Range | $14.73-$15.20 |
52W Range | $3.15-$26.95 |
Market Cap | $1.2B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.53 |
News
See moreYahoo Finance • last month
Corvus (CRVS) Q4 2025 Earnings Call Transcript
Yahoo Finance • last month
Corvus outlines cash runway into Q2 2028 and targets mid-2027 Phase II readout for soquelitinib in atopic dermatitis
Yahoo Finance • 4 months ago
Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial
About
CEO | Dr. Richard A. Miller M.D. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |
